JPH0488981A - Production of phospholipase d-k - Google Patents
Production of phospholipase d-kInfo
- Publication number
- JPH0488981A JPH0488981A JP2201799A JP20179990A JPH0488981A JP H0488981 A JPH0488981 A JP H0488981A JP 2201799 A JP2201799 A JP 2201799A JP 20179990 A JP20179990 A JP 20179990A JP H0488981 A JPH0488981 A JP H0488981A
- Authority
- JP
- Japan
- Prior art keywords
- phospholipase
- dna
- microorganism
- streptomyces
- genus streptomyces
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 title claims abstract description 55
- 102000015439 Phospholipases Human genes 0.000 title claims abstract description 55
- 108010064785 Phospholipases Proteins 0.000 title claims abstract description 55
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 108020004414 DNA Proteins 0.000 claims abstract description 56
- 244000005700 microbiome Species 0.000 claims abstract description 39
- 241000187747 Streptomyces Species 0.000 claims abstract description 28
- 108020004511 Recombinant DNA Proteins 0.000 claims abstract description 25
- 239000013598 vector Substances 0.000 claims abstract description 16
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 24
- 102000011420 Phospholipase D Human genes 0.000 abstract description 17
- 108090000553 Phospholipase D Proteins 0.000 abstract description 17
- 239000012634 fragment Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 10
- 210000004027 cell Anatomy 0.000 abstract description 8
- 108091008146 restriction endonucleases Proteins 0.000 abstract description 7
- 238000012258 culturing Methods 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 4
- 241000482007 Streptomyces acidomyceticus Species 0.000 abstract description 3
- 230000001580 bacterial effect Effects 0.000 abstract description 3
- 210000000349 chromosome Anatomy 0.000 abstract description 3
- 238000001962 electrophoresis Methods 0.000 abstract description 3
- 230000009466 transformation Effects 0.000 abstract description 3
- 150000003904 phospholipids Chemical class 0.000 abstract description 2
- 230000000704 physical effect Effects 0.000 abstract description 2
- 230000000813 microbial effect Effects 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 description 19
- 239000002609 medium Substances 0.000 description 18
- 239000000872 buffer Substances 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 239000000243 solution Substances 0.000 description 12
- 241000187398 Streptomyces lividans Species 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- 239000013611 chromosomal DNA Substances 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 239000012228 culture supernatant Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 241000186216 Corynebacterium Species 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 210000002969 egg yolk Anatomy 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 102000002322 Egg Proteins Human genes 0.000 description 5
- 108010000912 Egg Proteins Proteins 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 235000013345 egg yolk Nutrition 0.000 description 5
- 210000001938 protoplast Anatomy 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 238000012869 ethanol precipitation Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930185202 Thiopeptin Natural products 0.000 description 3
- IXEQUEFFDUXSRS-UGJHNBEYSA-N Thiopeptin Bb Natural products CC=C1NC(=O)[C@@H](NC(=O)c2csc(n2)[C@]34CCC(=N[C@@H]3c5csc(n5)[C@@H](NC(=S)c6csc(n6)[C@H](NC(=O)[C@@H]7CN=C1S7)[C@@](C)(O)[C@H](C)O)[C@H](C)OC(=O)c8cc([C@@H](C)O)c9C=C[C@@H](N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)NC(=C)C(=O)N[C@H](C)C(=O)N4)[C@@H](O)c9n8)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)O)[C@H](C)O IXEQUEFFDUXSRS-UGJHNBEYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- SRTDKHGZQCTGBY-RVDKCFQWSA-N thiopeptin Chemical compound N1C2C(N=3)=CSC=3C(C(C)OC(=O)C=3N=C4C(O)C(NC(C(C)C)C(=O)NC(C)C(=O)NC(=C)C(=O)NC(C)C(=O)N5)C=CC4=C(C(C)O)C=3)NC(=S)C(N=3)=CSC=3C(C(C)(O)C(C)O)NC(=O)C(N=3)CSC=3C(=C/C)\NC(=O)C(C(C)O)NC(=O)C(N=3)=CSC=3C25CCC1C1=NC(C(N)=O)=CS1 SRTDKHGZQCTGBY-RVDKCFQWSA-N 0.000 description 3
- 108010030742 thiopeptin Proteins 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- -1 glycerophospholipids Chemical compound 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- HALGLMAADGHVSV-UHFFFAOYSA-N 1-aminopropane-2-sulfonic acid Chemical compound NCC(C)S(O)(=O)=O HALGLMAADGHVSV-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- 241000187362 Actinomadura Species 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- HRVQDZOWMLFAOD-BIIVOSGPSA-N Asp-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N)C(=O)O HRVQDZOWMLFAOD-BIIVOSGPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- VFBZWZXKCVBTJR-SRVKXCTJSA-N His-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N VFBZWZXKCVBTJR-SRVKXCTJSA-N 0.000 description 1
- 101001040875 Homo sapiens Glucosidase 2 subunit beta Proteins 0.000 description 1
- 101000730665 Homo sapiens Phospholipase D1 Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 101000964266 Loxosceles laeta Dermonecrotic toxin Proteins 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100032967 Phospholipase D1 Human genes 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、リン脂質の定量や食品物性の改善等に用いら
れるホスホリパーゼD−にの新規製造法に関する。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a novel method for producing phospholipase D-, which is used for quantifying phospholipids and improving physical properties of foods.
従来技術
ホスホリパーゼD (EC3,1,4,4)は、ホスフ
ァチジルコリン特にグリセロリン脂質を加水分解し、ホ
スファチジン酸とコリンを生じる反応やホスファチジル
基の転移反応を触媒する酵素である。Prior Art Phospholipase D (EC3, 1, 4, 4) is an enzyme that hydrolyzes phosphatidylcholine, particularly glycerophospholipids, and catalyzes the reaction that produces phosphatidic acid and choline, and the transfer reaction of phosphatidyl groups.
ホスホリパーゼDは、ニンジン、キャベツ等ノ植物、ス
トレプトマイセス属〔ジャーナル オブバイオケミスト
リー(Journal of Biochemistr
y ;Tokyo)、 78巻、363頁、 1975
年;同185巻、79頁。Phospholipase D is found in plants such as carrots and cabbage, and in the genus Streptomyces [Journal of Biochemistry].
y ; Tokyo), vol. 78, p. 363, 1975
Year: Vol. 185, p. 79.
1979年;アクリカルチニラル アンド バイオロジ
カル ケミストリー(^gricultural an
d Biolo−gical Chemistry)、
37巻、 1667頁、 1973年;同。1979; Acrylicultural and Biological Chemistry
d Biolo-gical Chemistry),
Volume 37, page 1667, 1973;
53巻、 3083頁、 1989年〕ならびにアクチ
ノマジュラ属およびノカルデイア属[Agricult
ural andBiological Chemis
try、 48巻、 2181頁(1984年)〕など
に属する微生物に存在することが知られている。53, p. 3083, 1989] and the genera Actinomadura and Nocardia [Agricult
Ural and Biological Chemistry
try, Vol. 48, p. 2181 (1984)].
ストレプトマイセス・アンドマイセティカス株の生産す
るホスホリパーゼD−には、分子量54.000で、ホ
スファチジルコリン、ホスファチジルエタノールアミン
、ホスファチジルセリン、ホスファチシリル−グリセロ
ール、リゾホスファチジルコリン等を基質として、その
リン酸エステルを加水分解する酵素である〔特願平1−
44394号〕。Phospholipase D- produced by Streptomyces andmyceticus strain has a molecular weight of 54,000 and uses phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatisilyl-glycerol, lysophosphatidylcholine, etc. as a substrate and hydrates its phosphate ester. It is an enzyme that decomposes [Patent Application Hei 1-
No. 44394].
該酵素は至適温度が50〜75℃と高<、pH4,0〜
8.5の範囲で温度50℃で1時間加熱しても活性が低
下しない耐熱性酵素であり、Caイオンまたは界面活性
剤により活性化されないなど、前述のホスホリパーゼD
と異なる性質を有する新規なホスホリパーゼDである〔
特願平1−44394号〕。またかかる性質を有するホ
スホリパーゼD−には、食品の乳化に有用であり、該酵
素を用いた卵の改質が行われている〔特願平2−124
637号〕。The enzyme has an optimum temperature of 50-75°C and a pH of 4.0-75°C.
It is a thermostable enzyme whose activity does not decrease even when heated for 1 hour at a temperature of 50°C in the range of 8.5, and is not activated by Ca ions or surfactants.
It is a novel phospholipase D with different properties from [
Patent Application No. 1-44394]. Furthermore, phospholipase D-, which has such properties, is useful for emulsifying foods, and eggs have been modified using this enzyme [Patent Application No. 2-124]
No. 637].
家畜病のエンドトキ乙!であるコリネバクテリウム属微
生物由来のホスホリパーゼDに関して、該酵素のDNA
を抽出して大腸菌へクローニングしたこと〔インフェク
ンヨン アンド イミユニティ(Infection
and Immunity) 、 58巻、131頁。Livestock disease endotoki! Regarding phospholipase D derived from a microorganism of the genus Corynebacterium, the DNA of the enzyme
was extracted and cloned into Escherichia coli [Infection and Immiunity].
and Immunity), vol. 58, p. 131.
1990年〕が報告されているが、該酵素の生産量はス
フィンゴミエリンを基質とした場合培養液中0.005
U/mgと著しく少ない。該酵素のDNAをクローニン
グした大腸菌から得たコリネバクテリウム属微生物由来
のホスホリパーゼDのDNAの塩基配列も報告されてい
る〔ジャーナル オブバクテリオロジー(Journa
l of Bacteriology)。1990], but the production amount of this enzyme is 0.005% in the culture solution when sphingomyelin is used as a substrate.
It is extremely low at U/mg. The base sequence of the DNA of phospholipase D derived from a microorganism of the genus Corynebacterium obtained from Escherichia coli from which the DNA of the enzyme was cloned has also been reported [Journal of Bacteriology
l of Bacteriology).
172巻、 1256頁、 1990年(以下、文献1
という)〕。Volume 172, page 1256, 1990 (hereinafter referred to as Document 1)
)].
文献1によれば、コリネバクテリウム属微生物由来のホ
スホリパーゼDはホスホリパーゼD−K〔特願平1−4
4394号〕と異なり、分子量31.7KJalで活性
の発現にカルシウムイオンを必要とする。文献1に示さ
れたコリネバクテリウム属微生物由来のホスホリパーゼ
Dの塩基配列(上段)およびそれに対応するアミノ酸配
列(下段)を第1表に示す。According to Document 1, phospholipase D derived from a microorganism of the genus Corynebacterium is phospholipase D-K [Patent Application No. 1-4]
No. 4394], it has a molecular weight of 31.7 KJal and requires calcium ions to exhibit activity. Table 1 shows the base sequence (upper row) and the corresponding amino acid sequence (lower row) of phospholipase D derived from a microorganism of the genus Corynebacterium shown in Document 1.
以下余白
発明が解決しようとしている課題
ストレプトマイセス属微生物由来のホスホリパーゼD−
には食品加工等に有用であるが、ストレプトマイセス属
微生物での該酵素の生産量が少なく供給が限られている
。該酵素を大量に生産するためにより生産量の多い微生
物、特に培養液中に容易に該酵素を分易することのでき
る微生物を用いた製造法の開発が望まれている。The problem to be solved by the invention is phospholipase D derived from a microorganism of the genus Streptomyces.
The enzyme is useful in food processing, etc., but the production amount of the enzyme in Streptomyces microorganisms is small and supply is limited. In order to produce the enzyme in large quantities, it is desired to develop a production method using microorganisms that can produce larger quantities, especially microorganisms that can easily separate the enzyme into the culture solution.
課題を解決するための手段
本発明はストレプトマイセス属微生物に由来するホスホ
リパーゼD−KをコードするDNA、ストレプトマイセ
ス属微生物に由来するホスホリパーゼD−Kをコードす
るDNAをベクタ−DNAに組み込んだ組換えDNA、
ストレプトマイセス属微生物に由来するホスホリパーゼ
D−KをコードするDNAをベクタ−DNAに組み込ん
だ組換えDNAを含む微生物およびストレプトマイセス
属微生物に由来するホスホリパーゼD−Kをコードする
DNAをベクタ−DNAに組み込んだ組換えDNAを含
むストレプトマイセス属に属する微生物を、栄養培地に
培養し、培養物中にホスホリパーゼD−Kを生成蓄積さ
せ、該培養物からホスホリパーゼD−Kを採取すること
を特徴とするホスホリパーゼD−にの製造法に関する。Means for Solving the Problems The present invention incorporates DNA encoding phospholipase D-K derived from a microorganism of the genus Streptomyces into a vector DNA. recombinant DNA,
A microorganism containing a recombinant DNA in which DNA encoding phospholipase D-K derived from a microorganism of the genus Streptomyces is incorporated into a vector DNA, and a DNA encoding phospholipase D-K derived from a microorganism of the genus Streptomyces is incorporated into a vector DNA. A microorganism belonging to the genus Streptomyces containing the recombinant DNA incorporated into the culture medium is cultured in a nutrient medium, phospholipase D-K is produced and accumulated in the culture, and phospholipase D-K is collected from the culture. The present invention relates to a method for producing phospholipase D-.
以下に本発明の詳細な説明する。The present invention will be explained in detail below.
1、 ストレプトマイセス属微生物に由来するホスホリ
パーゼD−KをコードするDNAの抽出および該DNA
をベクタ−DNAに組み込んだ組換えDNAの製造:
ストレプトマイセス属に属する微生物からのホスホリパ
ーゼD−に遺伝子を含む染色体DNA0単離は常法によ
って、例えばカレント トピックス イン ÷イクロバ
イオロジー アントイミニノロジー(Current
Topics in Microbiologyand
Immunology)、95巻、 1982年(以
下、文献2という)、72頁に記載の方法によって行う
ことができる。1. Extraction of DNA encoding phospholipase D-K derived from Streptomyces microorganism and the DNA
Production of recombinant DNA incorporating into vector DNA: Chromosomal DNA containing the gene for phospholipase D from a microorganism belonging to the genus Streptomyces is isolated by a conventional method. (Current
Topics in Microbiology and
Immunology), Vol. 95, 1982 (hereinafter referred to as Document 2), p. 72.
染色体DNAを供与する微生物としてはホスホリパーゼ
D−にの生産能を有する微生物であればすべて使用可能
で、好適にはストレブトマイセス属微生物があげられる
。Any microorganism capable of producing phospholipase D- can be used as the microorganism that donates the chromosomal DNA, and microorganisms of the genus Strebtomyces are preferred.
ついで、該染色体DNAの組み込みは常法に従って、例
えば染色体DNAおよびベクタ−DNAを制限酵素で切
断して両DNAの断片を調製した後、両者の混合物をD
NA リガーゼで処理することによって行うことができ
る〔モレキュラー クローニング(Molecular
Cloning)。Next, the chromosomal DNA is integrated according to a conventional method, for example, by cutting the chromosomal DNA and the vector DNA with restriction enzymes to prepare fragments of both DNAs, and then dividing the mixture of the two into DNA fragments.
This can be done by treating with NA ligase [Molecular cloning].
Cloning).
ティー マニアティス(T、 Maniatis)ら編
、コールド スプリング ハーバ−ラボラトリ−(Co
lcl Spring )Iarbor Labora
tory)刊、 1982年(以下、文献3という)〕
。Edited by T. Maniatis et al., Cold Spring Harbor Laboratory (Co.
lcl Spring )Iarbor Labora
Tory), 1982 (hereinafter referred to as Document 3)]
.
ここで用いられるベクタ−DNAとしては、ストレプト
マイセス属に属する微生物内で組み込んだDNAを発現
させることができるものであれば、いずれも用いること
ができる。好ましくはストレプトマイセス・リビダンス
を宿主とすることが可能なプラスミドが用いられ、とり
わけpENlol(特開平1−304885号公報)。As the vector DNA used here, any vector can be used as long as it can express the incorporated DNA in a microorganism belonging to the genus Streptomyces. Preferably, a plasmid capable of using Streptomyces lividans as a host is used, particularly pENlol (Japanese Patent Application Laid-open No. 1-304885).
plJ’702(文献1,72頁)等を用いることが好
ましい。It is preferable to use plJ'702 (Reference 1, page 72).
また、DNAの切断に用いる制限酵素としては、例えば
市販(7)Bgβ■、BamHI、PstlSau3A
I等があげられる。5au3AIによる切断部位はBg
β■およびBamHIによる切断部位と同じ構造の突出
末端を生じるので、染色体DNAを5au3AIにより
限定分解して得られるDNA断片とBgβ■またはBa
mHIで切断したベクタ−DNA断片とは、容易に連結
することができる。DNAリガーゼとしては市販のT4
ファージ感染大腸菌由来のT4DNAリガーゼが用いら
れる。In addition, as restriction enzymes used for cutting DNA, for example, commercially available (7) Bgβ■, BamHI, PstlSau3A
Examples include I. The cleavage site by 5au3AI is Bg
Since a protruding end having the same structure as the cleavage site with β■ and BamHI is generated, the DNA fragment obtained by limited digestion of chromosomal DNA with 5au3AI and Bgβ■ or Ba
Vector DNA fragments cut with mHI can be easily ligated. Commercially available T4 is used as DNA ligase.
T4 DNA ligase derived from phage-infected E. coli is used.
このようにして得られた組換えDNAの例として例えば
プラスミドpPLD1があげられる。An example of the recombinant DNA thus obtained is plasmid pPLD1.
2、組換えDNAのストレプトマイセス属微生物への導
入および該微生物によるホスホリノ(−ゼD−にの製造
:
組換えDNAは、常法、例えば文献2.78頁に記載の
形質転換方法によってストレプトマイセス属微生物に導
入する〔特開平2−131577号公報〕。2. Introduction of recombinant DNA into a Streptomyces microorganism and production of phospholino(-zeD-) by the microorganism: The recombinant DNA is transformed into Streptomyces by a conventional method, for example, the transformation method described on page 2.78 of the literature. introduced into microorganisms of the genus Myces [JP-A-2-131577].
該組み換えDNAを含有する微生物は形質転換を施した
ストレプトマイセス属微生物のコロニーの中から例えば
下記のスクリーニング法によって選択する。The microorganism containing the recombinant DNA is selected from colonies of transformed microorganisms of the genus Streptomyces, for example, by the following screening method.
スクリーニング方法;
再生培地上に再生してきたストレプトマイセス属の形質
転換株をチオペプトン10jtg/−を含有する適当な
栄養寒天培地に植菌し、30℃で2日間培養を行う。コ
ロニーが生育してきたところで42℃に保温した卵黄寒
天培地(卵黄10%、寒天0.8%)を重層する。組換
えDNAを含有する菌株のコロニーでは、ホスホリパー
ゼD−に活性により卵黄が分割され透明なゾーンが周囲
に形成されるので、このようなコロニーを選択する。該
スクリーニングで得られるホスホリパーゼD−に活性が
、プラスミドベクタ−に連結されたストレプトマイセス
属に属するホスホリパーゼD−に生産菌株の染色体由来
の遺伝情報によることは、該菌株から抽出されたプラス
ミドDNAを用いて、再びストレプトマイセス・リビダ
ンスの形質転換を行うと、得られる形質転換体の全てが
ホスホリパーゼD−に生産性を示していることから確認
される。Screening method: The transformed strain of the genus Streptomyces regenerated on the regeneration medium is inoculated onto a suitable nutrient agar medium containing 10 jtg/- of thiopeptone, and cultured at 30°C for 2 days. When colonies have grown, an egg yolk agar medium (10% egg yolk, 0.8% agar) kept at 42° C. is layered. Colonies of strains containing recombinant DNA are selected because the activity of phospholipase D splits the yolk and forms a clear zone around it. The fact that the activity of the phospholipase D- obtained in this screening is due to the genetic information derived from the chromosome of the producing strain in the phospholipase D- belonging to the genus Streptomyces linked to the plasmid vector is that the plasmid DNA extracted from the strain is When Streptomyces lividans was transformed again using the transfectant, all of the transformants obtained were confirmed to be productive of phospholipase D-.
このようにして得られた組換えDNAを含有する微生物
の例として、例えばストレプトマイセス・リビダンスP
LDI株〈微工研条寄第2936号 平成2年5月25
日)があげられる。Examples of microorganisms containing recombinant DNA obtained in this manner include, for example, Streptomyces lividans P.
LDI stock <Feikoken Joyori No. 2936 May 25, 1990
day) can be given.
このようにして得られたPLDI等の微生物を、栄養培
地で液体培養することにより培養上清中に著量のホスホ
リパーゼD−Kが蓄積される。By liquid culturing the thus obtained microorganisms such as PLDI in a nutrient medium, a significant amount of phospholipase D-K is accumulated in the culture supernatant.
培養に用いられる培地としては、炭素源、窒素源、無機
物を含有する合成培地、または、天然培地のいずれも使
用できる。As the culture medium, either a synthetic medium containing a carbon source, a nitrogen source, and an inorganic substance, or a natural medium can be used.
炭素源としては、例えばグルコース、でんぷん、でんぷ
ん加水分解物、グリセロール、糖蜜など種々の炭水化物
が用いられ、その使用量は5〜TOg/l程度が好まし
い。また、窒素源としては、例えば硫酸アンモニウム、
リン酸アンモニウム、炭酸アンモニウム、酢酸アンモニ
ラム、ペプトン、酵母エキス、コーン・ステイープ・リ
カー、カゼイン加水分解物、肉エキス等の窒素含有有機
物等が用いられ、その使用量は5〜20g/f程度が好
ましい。さらに無機物としては、例えばリン酸第−水素
カリウム、リン酸第二水素カリウム、硫酸マグネシウム
、塩化マグネシウム等が用いられ、その使用量は0.0
5g/β〜5g/A程度が好ましい。As the carbon source, various carbohydrates such as glucose, starch, starch hydrolyzate, glycerol, and molasses are used, and the amount used is preferably about 5 to TOg/l. In addition, as a nitrogen source, for example, ammonium sulfate,
Nitrogen-containing organic substances such as ammonium phosphate, ammonium carbonate, ammonium acetate, peptone, yeast extract, corn steep liquor, casein hydrolyzate, meat extract, etc. are used, and the amount used is preferably about 5 to 20 g/f. . Further, as inorganic substances, for example, potassium hydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate, magnesium chloride, etc. are used, and the amount used is 0.0
About 5 g/β to 5 g/A is preferable.
ホスホリパーゼD−には、培養上清から精製して得るこ
とができる。Phospholipase D- can be obtained by purification from culture supernatant.
ホスホリパーゼD−にの精製は、該培養液から遠心分離
等の方法で菌体を除いた培養上清を、硫安塩析法、有機
溶媒沈澱法、イオン交換樹脂を用いるクロマトグラフィ
ー、ゲルを過、アフィニティークロマトグラフィー等の
常法を用いて行う。Purification of phospholipase D- is carried out by removing the culture supernatant from the culture solution by a method such as centrifugation, using ammonium sulfate salting out method, organic solvent precipitation method, chromatography using an ion exchange resin, gel filtration, This is carried out using conventional methods such as affinity chromatography.
3、 ホスホリパーゼD−KをコードするDNAの塩基
配列の決定:
ホスホリパーゼD−KをコードするDNAの塩基配列の
決定は、組換えDNAを含有するストレプトマイセス・
リビダンス中に存在する挿入プラスミドをBamHIに
よって切り出した2、 3 k bのDNA断片を、大
腸菌プラスミドのBamHI切断部位にクローン化した
後、決定しようとするDNA断片の両末端側からの種々
な欠失プラスミドを作成し、これらのプラスミドを保持
する形質転換株に、二重鎖DNAを一本鎖ファージに変
換させる“ためのヘルツ(−ファージを感染させて一本
鎖DNA (以下5sDNA)を調製し、該5sDNA
の塩基配列をグイデオキシ法の変法にしたがって決定す
ることにより行う。3. Determination of the base sequence of DNA encoding phospholipase D-K: Determination of the base sequence of DNA encoding phospholipase D-K was performed using Streptomyces spp. containing recombinant DNA.
After cloning a 2 to 3 kb DNA fragment excised from the insertion plasmid present in the lividans using BamHI into the BamHI cleavage site of an E. coli plasmid, various deletions from both ends of the DNA fragment to be determined were determined. Plasmids are created and transformants carrying these plasmids are infected with Hertz (-phage) to convert double-stranded DNA into single-stranded phage to prepare single-stranded DNA (hereinafter referred to as 5sDNA). , the 5sDNA
This is done by determining the nucleotide sequence of according to a modification of the guideeoxy method.
以下実施例をあげて本発明を具体的に説明する。The present invention will be specifically described below with reference to Examples.
実m例t、 ホスホリパーゼD−に遺伝子のクローニ
ング
(1〕 ホスホリパーゼD−に遺伝子を含む染色体D
NAの調製
ストレプトマイセス・アシドマイセテイカスIF031
25株をSK#2培地〔スタビロースK 20g/j
!、ペプトン 5g/β、 肉エキス 3g/A、KH
2P0.0.2g/I、MgCL 0.6g/l (
pH7,6) 〕30ml中、30℃で3日間振盪培養
した。得られた培養物を冷却遠心分離機(SCR18B
;日立工機製)を用いて4℃、11000rpの条件下
10分間遠心分離して集菌した。上清を除いた後、10
.3%ショ糖溶液で洗浄後再び遠心分離して菌体を集め
た。該菌体から文献2,72頁に記載された方法に従っ
て染色体DNAの抽出を行ない、約1■の染色体DNA
を得た。Example t, Cloning of the gene in phospholipase D- (1) Chromosome D containing the gene in phospholipase D-
Preparation of NA Streptomyces acidomyceticus IF031
25 strains were placed in SK#2 medium [Stabilose K 20g/j
! , peptone 5g/β, meat extract 3g/A, KH
2P0.0.2g/I, MgCL 0.6g/l (
[pH 7,6)] and cultured with shaking at 30°C for 3 days. The obtained culture was transferred to a refrigerated centrifuge (SCR18B
; manufactured by Hitachi Koki) for 10 minutes at 4° C. and 11,000 rpm to collect bacteria. After removing the supernatant, 10
.. After washing with a 3% sucrose solution, cells were collected by centrifugation again. Chromosomal DNA was extracted from the bacterial cells according to the method described in Reference 2, page 72, and about 1 inch of chromosomal DNA was extracted.
I got it.
(2)染色体DNA断片のベクタ−DNAへの導入(1
)で得られた染色体DNAl0■を、Mal衝液〔トリ
ス−塩酸緩衝液(pH7,5) 10mM、MgCJ
t 10mM、NaC150mM、ジチオスレイトー
ル(以下DTTという> 1mM) 5[10ρに溶
解した。このDNA溶液に制限エンドヌクL/7−ゼ5
au3AI (全酒造社製)10単位を添加し、37
℃で30分間部分分解を行った。(2) Introduction of chromosomal DNA fragment into vector DNA (1
) Chromosomal DNA10■ obtained in
t 10mM, NaC 150mM, dithiothreitol (hereinafter referred to as DTT > 1mM) 5[10mM] dissolved in 10mM. Add restriction endonuclease L/7-5 to this DNA solution.
10 units of au3AI (manufactured by Zenshuzo Co., Ltd.) were added, and 37
Partial decomposition was carried out for 30 minutes at °C.
部分分解されたDNAを文献3に記載されている方法に
従って、10−40%ンヨ糖密度勾配遠心分離を行った
。遠心分離(SCR18B;日立工機製)は20℃、2
600Orpmで16時間行い、遠心終了後分画を行っ
た。The partially degraded DNA was subjected to 10-40% sugar density gradient centrifugation according to the method described in Reference 3. Centrifugation (SCR18B; manufactured by Hitachi Koki) at 20°C, 2
The centrifugation was performed at 600 rpm for 16 hours, and fractionation was performed after centrifugation.
文献3の方法に従うアガロースゲル電気泳動により各分
画に含まれるDNA断片の大きさを測定した。3〜5k
bのDNA断片を含む分画のみを集めてエタノール沈澱
を行った後、エタノールを除き残存する沈澱(DNA断
片)4J1gを得た。得られた沈澱をライゲーション緩
衝液〔トリス−塩酸緩衝液(pH7,6) 66mM。The size of DNA fragments contained in each fraction was measured by agarose gel electrophoresis according to the method described in Reference 3. 3~5k
Only the fractions containing the DNA fragment of b were collected and subjected to ethanol precipitation, and then the ethanol was removed to obtain 4J1 g of the remaining precipitate (DNA fragment). The obtained precipitate was added to a ligation buffer [Tris-HCl buffer (pH 7,6) 66mM.
MgC1x 5mM5DTT 5mM、 AT’P
1mM)60ρに溶解し保存した。MgClx 5mM 5DTT 5mM, AT'P
1mM) and stored at 60ρ.
ベクタ−はpENlolを用い、その5gをM緩衝液1
50ρに溶解した。これに制限エンドヌクレアーゼ B
gln (ベーリンガーマンハイム社製)20単位を添
加し、37℃で3時間反応させて部分分解した後、LM
) IJスス−酸緩衝液(pH8,6)20I11と子
牛小腸由来アルカリ性ホスファターゼ(ベーリンガーマ
ンハイム社製)2単位を添加し、37℃で1時間脱リン
酸化反応を行った。反応液を65℃で10分間加熱して
酵素を完全に失活させた後、エタノール沈澱にて収集し
た沈澱をライゲーション緩衝液40〃に溶解した。pENlol was used as the vector, and 5 g of it was added to 1 ml of M buffer.
It was dissolved in 50ρ. Restriction endonuclease B
LM
) IJ soot-acid buffer (pH 8,6) 20I11 and 2 units of calf small intestine alkaline phosphatase (manufactured by Boehringer Mannheim) were added, and a dephosphorylation reaction was carried out at 37°C for 1 hour. After the reaction solution was heated at 65° C. for 10 minutes to completely inactivate the enzyme, the precipitate collected by ethanol precipitation was dissolved in ligation buffer 40°C.
染色体DNAを5au3Arで部分分解した溶液16I
jJtとpENlolをBgj!Ifで部分分解した溶
液5mとを混合し、ライゲーション緩衝液で全量75m
にした後、T4DNAリガーゼ(ベーリンガーマンハイ
ム社製)2単位を添加し、16℃で16時間連結反応を
行い組換えDNAを得た。Solution 16I in which chromosomal DNA was partially degraded with 5au3Ar
Bgj jJt and pENlol! Mix 5 ml of the partially decomposed solution with If, and make up the total volume to 75 ml with ligation buffer.
After that, 2 units of T4 DNA ligase (manufactured by Boehringer Mannheim) were added, and ligation reaction was carried out at 16° C. for 16 hours to obtain recombinant DNA.
(3)ホスホリパーゼD−KをコードするDNAを含む
組換えDNAによるストレプトマイセス・リビダンスT
K23株の形質転換
ホスホリパーゼD−KをコードするDNAを含む組換え
DNAをストレプトマイセス・リビダンスTK23株の
形質転換に供した。(3) Streptomyces lividans T using recombinant DNA containing DNA encoding phospholipase D-K
Transformation of the K23 strain The recombinant DNA containing the DNA encoding phospholipase D-K was used to transform the Streptomyces lividans TK23 strain.
ストレプトマイセス・リビダンスTK23株のプロトプ
ラストは、文献2.78頁に記載の方法に従って調製し
た。Protoplasts of Streptomyces lividans TK23 strain were prepared according to the method described on page 2.78 of the literature.
(2)で得た組換えDNA標品10gとP緩衝液〔ショ
糖 10.3%、N−トリス(ヒドロキンメチル)メチ
ル−2−アミノエタンスルホン酸(以下TMSというH
pH7,2) (側蓋)25mM。10 g of the recombinant DNA preparation obtained in (2), P buffer [sucrose 10.3%, N-tris(hydroquinemethyl)methyl-2-aminoethanesulfonic acid (hereinafter referred to as TMS)]
pH 7,2) (side lid) 25mM.
MgC1210mM、 CaC12(側蓋)25+++
M。MgC1210mM, CaC12 (side lid) 25+++
M.
K H2P O4(側蓋) 0.005%、ZTIC
1280j’g/ l、 F e C13・6 R2
0200g/l。K H2P O4 (side lid) 0.005%, ZTIC
1280j'g/l, Fe C13・6 R2
0200g/l.
CuCl2・2H201hg/I、MnCl2−4H2
0Log/l、Na2B<Oi’1OH2010■/
] 、 (NH4) 6M07024・4H2010
ag/ I 〕に懸濁したストレプトマイセス・リビダ
ンスTK23株のプロトプラスト100m(約10”個
/−)を混合し、室温で1分間放置後、440gのT緩
衝液(ポリエチレングリコール1000を25%となる
ようにP緩衝液に溶解した溶液)を添加混合した。該プ
ロトプラスト溶液にP緩衝液を加え全量を10艷に希釈
した後、R5再生寒天培地〔ショ糖 103g/l、グ
ルコース 10g/I、 イースト エクストラクト(
Difco社製) 5g/I、カザミノ酸(Dif
co社製)0.1g/l、に2S○40.25g/l、
MgC1z・6H2010,1g/l。CuCl2・2H201hg/I, MnCl2-4H2
0Log/l, Na2B<Oi'1OH2010■/
], (NH4) 6M07024・4H2010
100 m (approximately 10"/-) of Streptomyces lividans strain TK23 protoplasts suspended in 440 g of T buffer (25% polyethylene glycol 1000 and A solution dissolved in P buffer) was added and mixed. P buffer was added to the protoplast solution and the total volume was diluted to 10 μm, and then R5 regenerated agar medium [sucrose 103 g/l, glucose 10 g/l, East Extract (
Difco) 5g/I, casamino acid (Difco)
co) 0.1g/l, 2S○40.25g/l,
MgC1z・6H2010, 1g/l.
CaC12・2Ha○ 2.94g/j!(側蓋)。CaC12・2Ha○ 2.94g/j! (lateral lid).
KH2PO40,05g/l (側蓋) 、 N a
NO30,3g/l(側蓋)、グルタミン酸ナトリウ
ム0.03g/l(側蓋)、NaOH3g/l。KH2PO40.05g/l (side lid), Na
NO30, 3g/l (side lid), sodium glutamate 0.03g/l (side lid), NaOH 3g/l.
TES 5.73g/l、ZnC1,80g/]。TES 5.73g/l, ZnC1, 80g/].
FeCl3” 6H20200/l1g/l、CuC1
a’2H2010■/I、 MnC1,・4H201
0ttg/l、Na2B40t・10H2010ttg
/l。FeCl3” 6H20200/l1g/l, CuC1
a'2H2010■/I, MnC1,・4H201
0ttg/l, Na2B40t・10H2010ttg
/l.
(NH4)sMOtOa4’ 4H2010,q/1゜
バクトアガ−(Difco社製) 22 g/I Cp
H1,2) )に100n/プレートずつ塗布し、該培
地を30℃で16時間培養した。該プロトプラストと組
換えDNAの混合溶液を塗布した培地に、42℃に保温
したチオペプチン含有軟寒天重層培地〔普通ブイヨン培
地(Difco社製)8g/j!。(NH4)sMOtOa4' 4H2010,q/1° Bacto Agar (manufactured by Difco) 22 g/I Cp
H1,2)) was coated at 100n/plate, and the medium was cultured at 30°C for 16 hours. The medium coated with the mixed solution of protoplasts and recombinant DNA was coated with a thiopeptin-containing soft agar overlay medium kept at 42°C [regular bouillon medium (manufactured by Difco) 8 g/j! .
バクトアガー(Difco社製)5g/I1.チオペブ
チン200■/1〕を1プレートあたり、2.5rnI
!重層した後30℃で4日間培養を行った。Bact agar (manufactured by Difco) 5g/I1. Thiopebutin 200μ/1] per plate, 2.5rnI
! After layering, culture was performed at 30°C for 4 days.
プロトプラストに組換えDNAが導入されるとチオペブ
チン耐性を示すようになるが、このような形質転換株が
、約30000株得られた。When the recombinant DNA was introduced into protoplasts, they became resistant to thiopebutin, and about 30,000 such transformed strains were obtained.
(4)ホスホリパーゼD−KをコードするDNAを含む
組換えDNAを含有する形質転換体の選択(3)に示し
た方法により得られたストレプトマイセス・リビダンス
TK23株の形質転換株を滅菌した金属製の針を用いて
チオバブチン10鴻/−を含有するGPL培地〔グリセ
ロール20 g/l、ペプトン 20 g/j!、粗レ
シチン 1 0 g/ j’、 KNO30,5
g/ j!、 KH2P0゜0.5 g/ 1. M
g 304・7H200,5g/f。(4) Selection of transformants containing a recombinant DNA containing DNA encoding phospholipase D-K A metal sterilized transformant of Streptomyces lividans TK23 obtained by the method shown in (3) GPL medium containing thiovabutin 10 g/l [glycerol 20 g/l, peptone 20 g/j! , crude lecithin 10 g/j', KNO30.5
g/j! , KH2P0゜0.5 g/1. M
g 304.7H200, 5g/f.
Fe50<7H202Xl0−5g / 1 、 Mn
C1a ・4H202xlO−”g/l、Zn5O,−
78,02xlO−5g/J、寒天20g/L (p
H7,2):]に植菌し、30℃で2日間培養を行った
。コロニーが生育してきたところで、スクリーニングの
ため、42℃に保温した卵黄寒天培地(卵黄10%、寒
天0.8%)を1プレートあたり10m1重層し、37
℃で約15時間保温した。卵黄が分解され周囲に透明な
ゾーンを形成しているコロニー5株を選出し、該形質転
換株をチオペプチン10Jtg/mi!を含有するSK
#2培地10−を入れた大型試験管に植菌し、30℃で
2日間振盪培養を行った。この培養液を冷却遠心機(S
CR18B;日立工機製)を用いて、4℃10、000
rpmで10分間遠心分離し、培養上清を得た。該培養
上清中のホスホリパーゼD活性を特願平1−44394
号に記載した方法に準じて測定し、ホスホリパーゼD活
性を強く発現する形質転換株(PLDI株、微工研条寄
第2936号 平成2年5月25日)を取得した。Fe50<7H202Xl0-5g/1, Mn
C1a ・4H202xlO-"g/l, Zn5O,-
78,02xlO-5g/J, agar 20g/L (p
H7,2):] and cultured at 30°C for 2 days. When colonies have grown, for screening, layer 10 ml of egg yolk agar medium (10% egg yolk, 0.8% agar) kept at 42°C per plate, and
It was kept warm at ℃ for about 15 hours. Five colonies in which the egg yolk was decomposed and a clear zone was formed around them were selected, and the transformed strains were treated with thiopeptin at 10 Jtg/mi! SK containing
The cells were inoculated into a large test tube containing 10 - of #2 medium, and cultured with shaking at 30°C for 2 days. This culture solution was transferred to a refrigerated centrifuge (S
CR18B (manufactured by Hitachi Koki) at 4°C 10,000
Centrifugation was performed at rpm for 10 minutes to obtain a culture supernatant. The phospholipase D activity in the culture supernatant was determined using Japanese Patent Application No. 1-44394.
A transformed strain (PLDI strain, Kaikoken Joyori No. 2936, May 25, 1990) that strongly expressed phospholipase D activity was obtained.
ここで得られた形質転換株PLDI株より文献2.78
頁に記載されている方法に従ってプラスミドpPLD1
を抽出した。プラスミドpPLDlを用いて、(3)に
示した形質転換法に従って、再びストレプトマイセス・
リビダンスTK’23株の形質転換を行った。出現した
形質転換株のホスホリパーゼ生産性を上述のスクリーニ
ング法に従って測定したところ、測定したスヘての形質
転換株は、ホスホリパーゼD−にの生産性を示した。From the transformed strain PLDI strain obtained here, reference 2.78
Plasmid pPLD1 according to the method described on page
was extracted. Using plasmid pPLDl, Streptomyces was transformed again according to the transformation method shown in (3).
Lividans TK'23 strain was transformed. When the phospholipase productivity of the transformed strain that appeared was measured according to the above-mentioned screening method, the measured transformed strain showed productivity for phospholipase D-.
本形質転換株PLDI株の含有するプラスミドpPLD
1の制限酵素切断地図を第1図に示す。Plasmid pPLD contained in this transformed strain PLDI strain
The restriction enzyme cleavage map of No. 1 is shown in FIG.
(5)ホスホリパーゼD−にのDNAの塩基配列の決定
PLDI株中のプラスミド(pPLDl)のDNA10
xをM緩衝液(NaC1! 50mM。(5) Determination of DNA base sequence for phospholipase D- DNA10 of plasmid (pPLDl) in PLDI strain
x M buffer (NaCl! 50mM.
トリス−塩酸緩衝液(pH7,5)10mM。Tris-HCl buffer (pH 7,5) 10mM.
MgCJ!210mM、DTT 1rnM〕301I
!1に溶解し、BamHI(ベーリンガーマンハイム社
製)30単位で切断後、文献3,150〜163頁に記
載の方法に従って、2.3 k bのDNA断片3■を
回収した。MgCJ! 210mM, DTT 1rnM]301I
! 1 and cut with 30 units of BamHI (manufactured by Boehringer Mannheim), and 3 2.3 kb DNA fragments were recovered according to the method described in Reference 3, pp. 150-163.
大腸菌プラスミドのpUc119[:宝酒造社より購入
〕2■をM緩衝液20薦に溶解し、BamHI 10
単位で切断した後、フェノール処理、エタノール沈澱を
行った。得られた沈澱2■をトリス−塩酸緩衝液(pH
8,6)200mM 20mに溶解して、子牛胸腺由
来アルカリ性ホスファターゼ(ベーリンガーマンハイム
社製)1単位を用いて5′末端の脱リン酸化をした後、
65℃で15分間加熱し、さらにフェノール処理、エタ
ノール沈澱を行った。pPLDlからBamHIで切り
出した2、 3 k bの断片とBamHIで切断後脱
リン酸化したpUc1191■をそれぞれライゲーショ
ン緩衝液20ρに溶解した後混合し、T 4 DNA
’Jガーゼ1単位を用いてライゲーションを行った。Escherichia coli plasmid pUc119 [purchased from Takara Shuzo Co., Ltd.] 2■ was dissolved in M buffer 20%, BamHI 10%
After cutting into units, phenol treatment and ethanol precipitation were performed. The obtained precipitate 2■ was added to Tris-HCl buffer (pH
8,6) After dissolving in 200mM and dephosphorylating the 5' end using 1 unit of calf thymus alkaline phosphatase (manufactured by Boehringer Mannheim),
The mixture was heated at 65° C. for 15 minutes, and further subjected to phenol treatment and ethanol precipitation. A 2 to 3 kb fragment excised from pPLDl with BamHI and pUc1191 which had been cut with BamHI and dephosphorylated were dissolved in 20 ρ of ligation buffer and mixed, and T 4 DNA was added.
'Ligation was performed using 1 unit of J gauze.
該DNA標品を文献3,249〜251頁記載の方法に
従って大腸菌MV1184株〔宝酒造社より購入〕の形
質転換を行ったところ、両方向にホスホリパーゼD−に
の遺伝子を含む2、3 k bのBamHI切断片がp
Ucl、19のBamHI切断部位に挿入されたプラス
ミドクローンp P L Dseq lとp P L
Dseq 7を得た。When E. coli strain MV1184 [purchased from Takara Shuzo Co., Ltd.] was transformed with this DNA preparation according to the method described in Reference 3, pp. 249-251, a 2 to 3 kb BamHI gene containing the gene for phospholipase D- in both directions was transformed. The cut piece is p
Plasmid clones pPL Dseq l and pPL inserted into the BamHI cleavage site of Ucl, 19
Dseq 7 was obtained.
これらのプラスミドから〔メンド イン エンザイモロ
ジ−(Method in Enzymology)、
155巻、156頁、1987年〕に記載の方法に従
って欠失プラスミドを作成した。From these plasmids [Method in Enzymology]
A deletion plasmid was constructed according to the method described in [Vol. 155, p. 156, 1987].
該欠失プラスミドを用いて文献3,249頁記載の方法
に従って、大腸菌MV1184株の形質転換を行い、様
々な大きさの欠失プラスミドを有する形質転換株を作製
した。Using the deletion plasmids, E. coli MV1184 strain was transformed according to the method described in Reference 3, p. 249, to produce transformants having deletion plasmids of various sizes.
これらの形質転換株から[Method in Enz
ymology153巻、3頁、1987年および同、
101巻、20頁、1978年]に記載の方法に従って
、5sDNA 2■を調製した。From these transformed strains, [Method in Enz
ymology vol. 153, p. 3, 1987 and the same,
101, p. 20, 1978], 5sDNA 2■ was prepared.
該5sDNA断片の塩基配列の決定を5equanas
e■(東洋紡−Ll、 S、Biochemica1社
製)を用いたダイオキシン法の変法〔プロシーデインゲ
ス オブ ナショナル アカデミ−オブ サイエンス、
ニー ・ゲス・ニー (Proc、Natl、^ca
d 5ciII、S、A、)、 84巻、4767
頁、1987年〕に従って行った。The base sequence of the 5sDNA fragment was determined using 5equanas.
Modification of the dioxin method using e■ (Toyobo-Ll, S, manufactured by Biochemica 1) [Procedure of the National Academy of Sciences,
Nee Guess Nee (Proc, Natl, ^ca
d5ciII, S, A,), vol. 84, 4767
Page, 1987].
得られたストレプトマイセス由来のホスホリパーゼD−
にの塩基配列(上段)およびそれに対応するアミノ酸配
列(下段)を第2表に示す。The obtained Streptomyces-derived phospholipase D-
The nucleotide sequence (upper row) and the corresponding amino acid sequence (lower row) are shown in Table 2.
第
表
第2表によれば、決定されたDNA塩基配列の中には、
ホスホリパーゼD−にのタンパク質をエンドマン法〔ア
クタ ケミ力 スカンジナビア(^cta、 Chem
、 5cand、)、 227巻、283頁。According to Table 2, among the determined DNA base sequences,
Phospholipase D- protein was converted to phospholipase D using the Endoman method
, 5cand, ), vol. 227, p. 283.
1950年〕によって解析したときのN末端側からの1
0個のアミノ酸配列(Asp Ser Pro Thr
Pr。1 from the N-terminal side when analyzed by [1950]
0 amino acid sequences (Asp Ser Pro Thr
Pr.
His Leu Asp Ala Ala)を示す塩基
配列があり、タンパク質による部分分析結果と塩基の部
分分析結果が一致した。There was a base sequence showing His Leu Asp Ala Ala), and the results of partial protein analysis and base partial analysis matched.
また該塩基配列から推定されるホスホリパーゼD−にの
アミノ酸配列から分子量を計算すると53208となり
、該酵素の精製単一標品を電気泳動法〔ソディウム・ド
デシル・サルフェイト・ポリアクリルアミドゲル(以下
5DS−PAGEという)〕によって測定した分子量5
4 Kdal とほぼ一致し、コリネバクテリウム属微
生物由来のホスホリパーゼDの分子量31.7 Kda
l とは大きく異なった。さらにホスホリパーゼD−に
のアミノ酸配列とコリネバクテリウム属微生物由来のホ
スホリパーゼDのアミノ酸配列[Journal of
Bacteriology、 172巻、1256頁
1990年〕の間に相補性がなかった。Furthermore, when the molecular weight is calculated from the amino acid sequence of phospholipase D- deduced from the base sequence, it is 53,208, and a purified single specimen of the enzyme is subjected to electrophoresis [sodium dodecyl sulfate polyacrylamide gel (hereinafter referred to as 5DS- Molecular weight measured by PAGE)
4 Kdal, the molecular weight of phospholipase D derived from Corynebacterium microorganisms is 31.7 Kda.
It was very different from l. Furthermore, the amino acid sequence of phospholipase D- and the amino acid sequence of phospholipase D derived from a microorganism of the genus Corynebacterium [Journal of
Bacteriology, vol. 172, p. 1256, 1990].
実施例28組換え体DNAを含む微生物によるホスホリ
パーゼD−にの発酵生産
(1)ホスホリパーゼD−に遺伝子を含む組換え体プラ
スミドを含有するストレプトマイセス・リビダンス形質
転換株PLD1株の培養
実施例1により得られたストレプトマイセス・リビダン
ス形質転換株PLDI株をチオベプチンlO■/−を含
有するSK#2培地10−を入れた大型試験管に植菌し
、30℃で2日間振盪培養を行った。これを、チオペプ
チン10u / rnl!を含有するSK#2培地50
0−を入れた21型バツフル付三角フラスコに植菌し、
30℃で16時間振盪培養を行った。このようにして得
られた培養液を冷却遠心機(SCR18B;日立工機製
)を用いて4℃、 8000rpmで20分間遠心し、
菌体を除いて培養上清400m1!を得た。Example 28 Fermentative production of phospholipase D- by a microorganism containing recombinant DNA (1) Cultivation of Streptomyces lividans transformed strain PLD1 strain containing a recombinant plasmid containing the gene for phospholipase D- Example 1 The Streptomyces lividans transformed strain PLDI strain obtained was inoculated into a large test tube containing 10 - of SK#2 medium containing 10/- of thiobeptin, and cultured with shaking at 30°C for 2 days. . Add this to thiopeptin 10u/rnl! SK#2 medium containing 50
Inoculate a 21-type Erlenmeyer flask with a double-sided tube containing 0-,
Shaking culture was performed at 30°C for 16 hours. The culture solution thus obtained was centrifuged at 4°C and 8000 rpm for 20 minutes using a refrigerated centrifuge (SCR18B; manufactured by Hitachi Koki).
Culture supernatant 400ml excluding bacterial cells! I got it.
得られた培養土浦中のホスホリパーゼD−に活性を特願
平144394号に記載された方法に準じて測定したと
ころ、15U/mfの最高力価を示した。この力価は形
質転換に用いたホスホリパーゼD−に遺伝子の供与菌株
であるストレプトマイセス・アシドマイセティカスIF
03125株の場合の最高力価10/−より15倍高か
った。When the activity of phospholipase D in the obtained cultured Tsuchiura was measured according to the method described in Japanese Patent Application No. 144394, it showed a maximum titer of 15 U/mf. This titer was determined from Streptomyces acidomyceticus IF, which is the gene donor strain for phospholipase D- used for transformation.
It was 15 times higher than the maximum titer of 10/- for the 03125 strain.
(2〕 組換え体ホスホリパーゼD−にの精製本実施
例で得た培養上清400−に、硫酸アンモニウム120
gを徐々に添加攪拌し1時間放置した。生じた沈澱を冷
却遠心機(SCR18B;日立工機製)を用い4℃、8
000rpmで20分間遠心して除去した。(2) Purification of recombinant phospholipase D-120 ammonium sulfate was added to 400-40% of the culture supernatant obtained in this example.
g was gradually added, stirred, and left for 1 hour. The resulting precipitate was centrifuged at 4°C at 8°C using a refrigerated centrifuge (SCR18B; manufactured by Hitachi Koki).
It was removed by centrifugation at 000 rpm for 20 minutes.
得られた上清に硫酸アンモニウム120gを添加攪拌し
、1時間放置した後前述と同様の条件で遠心し、沈澱を
得た。得られた沈澱を50mM)リス−マレイン酸緩衝
液(pH8,0)20mlに溶解し、透析による脱塩を
行った。同硫安画分での収率は約90%であった。120 g of ammonium sulfate was added to the obtained supernatant, stirred, allowed to stand for 1 hour, and then centrifuged under the same conditions as above to obtain a precipitate. The obtained precipitate was dissolved in 20 ml of 50 mM) lis-maleic acid buffer (pH 8,0), and desalted by dialysis. The yield of the ammonium sulfate fraction was about 90%.
溶出画分を50mM)IJス塩酸緩衝液(pH7,5)
テ平衡化したD E A E −3epharose
CL6Bカラム(約100me)に通塔した。カラムを
さらに5QmM)!Jス塩酸緩衝液で洗浄すると、ホス
ホリパーゼD−Kを含む両分が溶出されこれを採取した
。Add the elution fraction to 50mM) IJS hydrochloric acid buffer (pH 7.5)
Equilibrated DEAE-3epharose
It was passed through a CL6B column (approximately 100 me). Add another 5QmM) to the column! When washed with JS hydrochloric acid buffer, both components containing phospholipase D-K were eluted and collected.
この段階でのホスホリパーゼD−にの収率は90%であ
った。The yield of phospholipase D- at this stage was 90%.
該溶出画分の一部を5DS−PAGE電気泳動に付した
ところホスホリパーゼD−Kに相当する位置に単一バン
ドが示された。When a part of the elution fraction was subjected to 5DS-PAGE electrophoresis, a single band was observed at the position corresponding to phospholipase D-K.
発明の効果
本発明によれば、ストレプトマイセス属由来のホスホリ
パーゼD−KをコードするDNAをベクタ−DNAに組
み込んだ組換え体DNAおよび該組換え体DNAを含む
微生物が得られ、これらはストレプトマイセス属由来の
ホスホリパーゼD−にの大量生産に利用することができ
る。Effects of the Invention According to the present invention, a recombinant DNA in which a DNA encoding phospholipase D-K derived from the genus Streptomyces is incorporated into a vector DNA and a microorganism containing the recombinant DNA are obtained, and these It can be used for mass production of phospholipase D- derived from Myces.
第1図にホスホリパーゼD−にの遺伝子を含むプラスミ
ドpPLD1の制限酵素切断地図を示す。
第1図FIG. 1 shows a restriction enzyme cleavage map of plasmid pPLD1 containing the gene for phospholipase D-. Figure 1
Claims (4)
パーゼD−KをコードするDNA。(1) DNA encoding phospholipase D-K derived from a microorganism of the genus Streptomyces.
パーゼD−KをコードするDNAをベクタ−DNAに組
み込んだ組換えDNA。(2) A recombinant DNA in which a DNA encoding phospholipase D-K derived from a microorganism of the genus Streptomyces is incorporated into a vector DNA.
パーゼD−KをコードするDNAをベクタ−DNAに組
み込んだ組換えDNAを含む微生物。(3) A microorganism containing a recombinant DNA in which DNA encoding phospholipase D-K derived from a Streptomyces microorganism is incorporated into a vector DNA.
パーゼD−KをコードするDNAをベクタ−DNAに組
み込んだ組換えDNAを含むストレプトマイセス属に属
する微生物を、栄養培地に培養し、培養物中にホスホリ
パーゼD−Kを生成蓄積させ、該培養物からホスホリパ
ーゼD−Kを採取することを特徴とするホスホリパーゼ
D−Kの製造法。(4) A microorganism belonging to the genus Streptomyces containing a recombinant DNA in which DNA encoding phospholipase D-K derived from a microorganism of the genus Streptomyces has been incorporated into a vector DNA is cultured in a nutrient medium, and a A method for producing phospholipase D-K, which comprises producing and accumulating phospholipase D-K and collecting phospholipase D-K from the culture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2201799A JP3006856B2 (en) | 1990-07-30 | 1990-07-30 | Method for producing phospholipase DK |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2201799A JP3006856B2 (en) | 1990-07-30 | 1990-07-30 | Method for producing phospholipase DK |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0488981A true JPH0488981A (en) | 1992-03-23 |
JP3006856B2 JP3006856B2 (en) | 2000-02-07 |
Family
ID=16447125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2201799A Expired - Lifetime JP3006856B2 (en) | 1990-07-30 | 1990-07-30 | Method for producing phospholipase DK |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3006856B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2011033961A1 (en) * | 2009-09-15 | 2013-02-14 | 国立大学法人東京海洋大学 | Phospholipase A1, gene encoding phospholipase A1, expression vector, transformant, and method for producing phospholipase A1 |
-
1990
- 1990-07-30 JP JP2201799A patent/JP3006856B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2011033961A1 (en) * | 2009-09-15 | 2013-02-14 | 国立大学法人東京海洋大学 | Phospholipase A1, gene encoding phospholipase A1, expression vector, transformant, and method for producing phospholipase A1 |
Also Published As
Publication number | Publication date |
---|---|
JP3006856B2 (en) | 2000-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DENNIS et al. | Enzymatic synthesis and decarboxylation of phosphatidylserine in Tetrahymena pyriformis | |
Mayer et al. | Restriction endonucleases: general survey procedure and survey of gliding bacteria | |
JPH0488981A (en) | Production of phospholipase d-k | |
JP2886547B2 (en) | Method for producing neuraminidase | |
EP0537553B1 (en) | Farnesyl pyrophosphate synthetase and DNA sequence encoding the same | |
US4161424A (en) | Novel endonuclease and process for production thereof | |
EP1535999B1 (en) | Milk-coagulating enzyme originating in bacterium and process for producing cheese using the same | |
JPH062061B2 (en) | Process for producing N-acetylneuraminic acid lyase | |
Chen et al. | Flavobacterium piscinae sp. nov., isolated from a fish pond | |
Chen et al. | Flavobacterium stagni sp. nov., isolated from a freshwater reservoir | |
JP2017060424A (en) | Lipases, polynucleotides, recombinant vectors, transformants, methods of producing lipase, methods of hydrolyzing glycerolipid and methods of producing glycerolipid hydrolysate | |
JPS6362195B2 (en) | ||
EP1099755A1 (en) | Novel gene and transformant carrying the same | |
JP2615090B2 (en) | Plasmids and Escherichia coli transformed therewith | |
JPS6374491A (en) | Production of protein | |
JPH11510702A (en) | Novel stereospecific glycerol phosphatase | |
JPH0515387A (en) | Decomposition of alginic acid with bacterium | |
JPH0458884A (en) | New restrictive enzyme | |
DK157562B (en) | PROCEDURE FOR PREPARING AT LEAST TWO DEOXYRIBONUCLEASES | |
SU1724689A1 (en) | Method for preparation of restriction endonuclease, recognizing and splitting the nucleotide sequence 5ъtgatca3ъ | |
US5470732A (en) | Restriction enzyme from Brevibacterium linens | |
WO2008136451A1 (en) | Sphingomyelinase | |
SU1440919A1 (en) | Strain of kurthia zopfii bacteria as producer of restrictive endonuclease | |
JPS59159778A (en) | Preparation of heat-resistant leucine dehydrogenase | |
Nauyalis et al. | Isolation, characterization and protein and polar lipid compositions of Paracoccus denitrificans outer membrane |